Neogen Chemicals Limited (NEOGEN)
Outcome of Board Meeting
Q2FY27 results (unaudited):
Standalone:
Revenue 28.8bn +39% y-y (20.7bn)
PAT 2.11bn +127% y-y (0.93bn)
Half year FY27 results (unaudited):
Standalone:
Revenue 54.0bn +38% y-y (39.1bn)
PAT 4.06bn +73% y-y (2.36bn)
FY26 results (audited):
Standalone:
Revenue 85.5bn +20% y-y (71.3bn)
EBITDA 6.31bn +6% y-y (5.95bn)
EBITDA margin 7.4% (8.3%) -90 bps y-y
PAT 4.70bn +7% y-y (4.39bn)
Consolidated:
Revenue 86.2bn +20% y-y (71.0bn)
EBITDA 8.27bn +4% y-y (7.95bn)
EBITDA margin 9.6% (11.2%) -160 bps y-y
PAT 2.88bn -8% y-y (3.13bn)
Dividend: None declared
Commentary: The company completed a QIP raising 60bn gross proceeds in Q2FY27; proceeds to be used for debt repayment, working capital and general corporate purposes. The company is recovering insurance claims related to a March 2025 fire incident with net claim receivable of 17.2bn as of September 30, 2026, and an additional 15.2bn approved post quarter. No deviation in QIP fund usage reported.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 NEOGEN — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add NEOGEN to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Neogen Chemicals Limited
Important.
The summary above is generated automatically from Neogen Chemicals Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.